Conditions: Chronic Obstructive Pulmonary Disease
Keywords: COPD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1200
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if SYMBICORT® delivered via a pressurized metered-dose inhaler, referred to as a pMDI, is effective in preventing COPD exacerbations.

Detailed description:

Arms:

Interventions: intervention 1: Budesonide/formoterol (SYMBICORT) pMDI intervention 2: Formoterol Turbuhaler
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: